Literature DB >> 3931082

The murine bm12 gene conversion provides evidence that T cells recognize predominantly Ia conformation.

H Y Tse, S Kanamori, W D Walsh, T H Hansen.   

Abstract

The structure of the highly polymorphic Ia dimer is the genetically determined factor that controls the immune response to foreign antigens, albeit the mechanism remains unresolved. However, it is clear that, in diverse immune responses, effector T lymphocytes require recognition of self-Ia and foreign antigenic determinants on the surface of an antigen-presenting cell or an antibody-secreting B cell. Furthermore, a single Ia molecule has been found to possess several independently acting functional domains. In this report T-cell recognition of Ia was limited to a single, defined structure by using the Ia mutant mouse strain B6.C-H-2bm12 (bm12). The Ia determinant being recognized is the site of the mutation that represents a difference in three of five amino acid residues in a hypervariable region of its beta chain. This mutation has been proposed to have resulted from a gene conversion-like event and is known to have functional importance. Recognition of the bm12 mutation site was studied here in in vitro cultures of T cells generated against Iabm12 antigens. The specificity of these alloreactive T cells was tested by using stimulator cells expressing various Ia alloantigens of known structure. Our findings provide direct genetic evidence that T cells recognize predominantly conformational determinants on Ia molecules and not their primary structure. The implications of these findings on our understanding of the genetic control of the immune response and the potential to modulate these responses in an antigen-specific way are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931082      PMCID: PMC391309          DOI: 10.1073/pnas.82.20.7058

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Fine specificity of cloned insulin-specific T cell hybridomas: evidence supporting a role for tertiary conformation.

Authors:  L H Glimcher; J A Schroer; C Chan; E M Shevach
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

Review 2.  The class II molecules of the human and murine major histocompatibility complex.

Authors:  J F Kaufman; C Auffray; A J Korman; D A Shackelford; J Strominger
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

3.  Recognition of conformational determinants on H-2 by cytolytic T lymphocytes.

Authors:  L A Sherman
Journal:  Nature       Date:  1982-06-10       Impact factor: 49.962

4.  A molecular map of the immune response region from the major histocompatibility complex of the mouse.

Authors:  M Steinmetz; K Minard; S Horvath; J McNicholas; J Srelinger; C Wake; E Long; B Mach; L Hood
Journal:  Nature       Date:  1982-11-04       Impact factor: 49.962

5.  Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes.

Authors:  D J Mathis; C Benoist; V E Williams; M Kanter; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  A possible immunodominant epitope recognized by murine T lymphocytes immune to different myoglobins.

Authors:  I Berkower; G K Buckenmeyer; F R Gurd; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  T cell responses to select Ia determinants using the I-A mutant mouse strain B6.C-H-2bm12.

Authors:  R R Skelly; F Pappas; S Koprak; A Ahmed; T H Hansen
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

8.  Selective loss of antigen-specific Ir gene function in IA mutant B6.C-H-2bm12 is an antigen presenting cell defect.

Authors:  C C Lin; A S Rosenthal; H C Passmore; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Gain/loss of poly(Glu50Tyr50)/poly(Glu60Ala30Tyr10) responsiveness in the bm12 mutant strain.

Authors:  H Y Lei; R W Melvold; S D Miller; C Waltenbaugh
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

10.  The I-Ab mutant B6.C-H-2bm12 allows definition of multiple T cell epitopes on I-A molecules.

Authors:  B N Beck; P A Nelson; C G Fathman
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

View more
  7 in total

1.  Specific T suppressors and cytotoxic T lymphocytes recognize different epitopes on Abbm12 molecule.

Authors:  E V Fedoseyeva; S G Apasov; A V Chervonsky
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  Cotransfer of the Ed alpha and Ad beta genes into L cells results in the surface expression of a functional mixed-isotype Ia molecule.

Authors:  B Malissen; N Shastri; M Pierres; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

3.  Mutation in the A beta gene of B6.C-H-2bm12 generates unique T-cell recognition sites.

Authors:  K A Donovan; S K Singh; C S David
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 4.  T cells, murine chronic graft-versus-host disease and autoimmunity.

Authors:  Robert A Eisenberg; Charles S Via
Journal:  J Autoimmun       Date:  2012-06-16       Impact factor: 7.094

5.  Molecular genetic analysis of 178 I-Abm12-reactive T cells.

Authors:  J Bill; J Yagüe; V B Appel; J White; G Horn; H A Erlich; E Palmer
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

6.  Identification of an immunodominant region on the I-A beta chain using site-directed mutagenesis and DNA-mediated gene transfer.

Authors:  J M Buerstedde; L R Pease; M P Bell; A E Nilson; G Buerstedde; D Murphy; D J McKean
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

7.  Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance.

Authors:  Marta Consuegra-Fernández; Mario Martínez-Florensa; Fernando Aranda; José de Salort; Noelia Armiger-Borràs; Teresa Lozano; Noelia Casares; Juan José Lasarte; Pablo Engel; Francisco Lozano
Journal:  Front Immunol       Date:  2017-05-30       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.